Hubei Jumpcan Pharmaceutical announced that its wholly-owned subsidiary, Hubei Jumpcan Pharmaceutical Group Co., Ltd., has successfully negotiated to include its products, Pediatric Chiqiao Qingre Syrup and Fexofenadine Hydrochloride Dry Suspension, for the first time in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024).
- Latest
- Detail
济川药业:子公司两产品首次纳入国家医保目录
hubei jumpcan pharmaceutical: Two products of its subsidiary are included in the national medical insurance catalog for the first time.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
15:46
fujian issued a 15-year special local government bond for toll roads, with a scale of 0.09 billion yuan, an issuance interest rate of 2.2100%, a marginal multiple of 9.50 times, and an expected multiple of 2.17; fujian issued a 7-year special local government bond for high-quality development, with a scale of 0.11775 billion yuan, an issuance interest rate of 1.9000%, a marginal multiple of 3.31 times, and an expected multiple of 1.93.
15:46
D.A. Davidson: Raised Salesforce's target price from $250 to $300, maintaining a "neutral" rating.
CRM+10.99%
15:45
Sungrow Power Supply Vice Chairman Gu Yilei: Oppose disordered low stock price competition.
Sungrow Power Supply-1.26%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.